SWOG
- Country
- đēđ¸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
- Conditions
- Adult RhabdomyosarcomaAdult Brain Malignant HemangiopericytomaAdult Malignant MeningiomaChondrosarcomaAdult FibrosarcomaAdult Leiomyosarcoma
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 7
- Registration Number
- NCT00003292
- Locations
- đĩđˇ
San Juan City Hospital, San Juan, Puerto Rico
đēđ¸CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
đēđ¸Mercy Medical Center, Des Moines, Iowa, United States
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 41
- Registration Number
- NCT00028769
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸CCOP - Atlanta Regional, Atlanta, Georgia, United States
đēđ¸CCOP - Central Illinois, Decatur, Illinois, United States
BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00016965
- Locations
- đēđ¸
University of Rochester Medical Center, Rochester, New York, United States
đēđ¸MBCCOP - Gulf Coast, Mobile, Alabama, United States
đēđ¸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
- Conditions
- Esophageal CancerGastric Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00032123
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States
đēđ¸Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States
Arsenic Trioxide in Treating Men With Germ Cell Cancer
- Conditions
- Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00036842
- Locations
- đēđ¸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
đēđ¸MBCCOP - Gulf Coast, Mobile, Alabama, United States
đēđ¸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Stage IV Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00042783
- Locations
- đēđ¸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
đēđ¸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00016393
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States
đēđ¸Oregon Cancer Institute, Portland, Oregon, United States
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 76
- Registration Number
- NCT00041067
- Locations
- đēđ¸
Northern Rockies Radiation Oncology Center, Billings, Montana, United States
đēđ¸Great Falls Clinic, Great Falls, Montana, United States
đēđ¸Billings Clinic Cancer Center, Billings, Montana, United States
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
- Conditions
- Extrahepatic Bile Duct CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 57
- Registration Number
- NCT00033540
- Locations
- đēđ¸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
đēđ¸Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
đēđ¸North Bay Cancer Center, Fairfield, California, United States
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 671
- Registration Number
- NCT00045162
- Locations
- đēđ¸
Northside Hospital Cancer Center, Atlanta, Georgia, United States
đēđ¸Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
đēđ¸MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States